Prof. Michelle E. Armstrong is a Professor of Translational Respiratory Medicine at Trinity College Dublin, where she investigates immune responses in lung diseases and develops nano-based therapies for conditions such as idiopathic pulmonary fibrosis (IPF) and allergic airway inflammation. Her research has revealed key genetic determinants of disease severity and pioneered new therapeutic approaches. With a BSc/MSc in Biomedical Science and a PhD in Molecular Neuroendocrinology from the University of Cambridge, Prof Armstrong combines rigorous academic training with translational ambition, making her a vital contributor to the development of next-generation respiratory medicine.
Prof. Michelle Armstrong
TRP020; Lead PI
TCD
michelle.armstrong@tcd.ie
Prof. Michelle E. Armstrong is a Professor of Translational Respiratory Medicine at Trinity College Dublin, where she investigates immune responses in lung diseases and develops nano-based therapies for conditions such as idiopathic pulmonary fibrosis (IPF) and allergic airway inflammation. Her research has revealed key genetic determinants of disease severity and pioneered new therapeutic approaches. With […]
Last Updated:
Research Areas:
Research Programmes
Related News

Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...

New €31.6 million ARC Hub for Therapeutics to turn breakthrough Irish research into therapies and companies
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
